Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial
PaperCitations, authors & open-access status
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 54 citations, 2025 year and hybrid oa status.
54
Citations
2025
Year
hybrid
OA Status